SPA
MLAB icon

Sherbrooke Park Advisers’s Mesa Laboratories MLAB Stock Holding History

Sherbrooke Park Advisers’s Portfolio MLAB Stock Details MLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,840
Closed -$239K – 1011
2024
Q3 		$239K Buy
+1,840
New +$216K 0.05% 674

Other funds holding MLAB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Sherbrooke Park Advisers's MLAB Position: Q4 2024 in Review

Sherbrooke Park Advisers sold out of Mesa Laboratories (MLAB) in Q4 2024, closing a stake of 1,840 shares — an estimated $239K sold.

Sherbrooke Park Advisers first reported a position in MLAB in Q3 2024 and held it in 1 quarter. The position peaked at $239K in Q3 2024. 156 funds tracked by Wall St. Rank hold MLAB as of Q4 2024.

  • Sherbrooke Park Advisers reported no remaining Mesa Laboratories position as of Q4 2024 after selling out during the quarter.
  • Sherbrooke Park Advisers sold 1,840 Mesa Laboratories shares in Q4 2024, an estimated $239K.
  • Sherbrooke Park Advisers first reported a position in Mesa Laboratories in Q3 2024 and held it in 1 quarter.
  • Sherbrooke Park Advisers's Mesa Laboratories position peaked at $239K in Q3 2024.
  • 156 funds tracked by Wall St. Rank held Mesa Laboratories as of Q4 2024.

Based on Sherbrooke Park Advisers's 13F filing for Q4 2024, filed 14 Feb 2025.